NewsRadio WFLA (WFLA-AM)
American Medicine Today (AMT) - Kimberly Bonati, Ethan Youker & Spine surgeon Alfred Bonati, M.D. (innovation, medicine & politics)
11/30/24 S11 E0350- WHAT’S NEW SEGMENT- DR. BONATI : GENE THERAPY
11/30/24 S11 E0350- WHAT’S NEW SEGMENT- DR. BONATI : GENE THERAPY
11/30/24 S11 E0350- WHAT’S NEW SEGMENT- DR. BONATI : GENE THERAPY
Saturday 30th November 2024
Dive into gene therapy's potential to transform healthcare with Dr. Bonati's insights on American Medicine Today.
Explicit
12 minutes
Informative
Engaging
Inspiring
Educational
Thought-provoking
About this podcast
Author:
NewsRadio WFLA (WFLA-AM)
Overview:
Categories:
Innovative Treatments & Recovery Paths
Holistic Health Innovations
Innovative Healing Arts
Sexual Stigmas & Myths
Mindful Recovery
Links:
Visit site
Episodes:
1274 (View all)
Do you want to link to this podcast?
Get the buttons here!Gene Therapy: Cutting-Edge Science or Costly Dream?
Episode Overview
- Gene therapy holds promise for treating hemophilia B and other serious conditions.
- CRISPR technology allows precise editing of genes to potentially offer lifelong cures.
- The cost of gene therapy remains a significant barrier to accessibility.
- Big Pharma's involvement may impact pricing and availability of treatments.
- Gene therapy could extend human lifespan and improve quality of life.
"Imagine a room full of garbage, and you have a big broom to get the garbage out"
American Medicine Today, a podcast known for its dynamic blend of medical innovations and political commentary, brings listeners a fascinating discussion on gene therapy. Dr. Alfred Bonati, a renowned spine surgeon, takes centre stage as he explores the potential of gene therapy to revolutionise treatment for conditions like hemophilia B, sickle cell anaemia, and even deadly sarcomas. With cutting-edge techniques like CRISPR, scientists are essentially wielding microscopic scissors to edit genes and potentially offer lifelong cures.
Imagine a future where the need for constant transfusions or the fear of bleeding becomes a thing of the past for hemophilia patients. Dr. Bonati also touches on the possibility of extending human longevity and improving quality of life through gene therapy, although he cautions about the hefty price tag associated with such treatments. The episode is sprinkled with light-hearted banter as co-hosts Kimberly Bonati and Ethan Youker navigate the complexities of gene therapy and its implications on healthcare costs.
The conversation takes an interesting turn as they ponder the involvement of Big Pharma and its potential impact on accessibility and pricing. With its engaging mix of science and speculation, this episode offers listeners a glimpse into the future of medicine and its exciting possibilities. If you're curious about how gene therapy might change the landscape of healthcare, this episode is a must-listen.